Milestone Pharmaceuticals Inc
(MIST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,717 | -10,354 | -59,685 | -46,074 | -30,993 |
| Depreciation Amortization | 54 | N/A | 92 | 66 | 42 |
| Other Working Capital | 229 | -899 | 1,243 | 105 | 894 |
| Other Operating Activity | 4,447 | 2,319 | 11,926 | 9,275 | 5,589 |
| Operating Cash Flow | $-14,987 | $-8,934 | $-46,424 | $-36,628 | $-24,468 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17,525 | -27,014 | 4,868 | -8,839 | 2,000 |
| PPE Investments | -7 | N/A | -112 | -81 | -63 |
| Investing Cash Flow | $-17,532 | $-27,014 | $4,756 | $-8,920 | $1,937 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 50,000 | 50,000 | 50,000 |
| Common Stock Issued | 32,021 | 32,319 | 574 | 573 | 268 |
| Other Financing Activity | 0 | 0 | -2,782 | -2,782 | -2,782 |
| Financing Cash Flow | $32,021 | $32,319 | $47,792 | $47,791 | $47,486 |
| Beginning Cash Position | 13,760 | 13,760 | 7,636 | 7,636 | 7,636 |
| End Cash Position | 13,262 | 10,131 | 13,760 | 9,879 | 32,591 |
| Net Cash Flow | $-498 | $-3,629 | $6,124 | $2,243 | $24,955 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,987 | -8,934 | -46,424 | -36,628 | -24,468 |
| Capital Expenditure | -7 | N/A | -112 | -81 | -63 |
| Free Cash Flow | -14,994 | -8,934 | -46,536 | -36,709 | -24,531 |